Terms: = Lymphoma AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
44 results:
1. A Rare Case of Non-IgM Lymphoplasmacytic lymphoma with Unusual Lack of Immunoglobulin Light Chain Production.
Yin J; Bains A; Alsammak M; Fu JJ
Am J Case Rep; 2024 Mar; 25():e940963. PubMed ID: 38437184
[TBL] [Abstract] [Full Text] [Related]
2. Research Progress of cxcr4-Targeting Radioligands for Oncologic Imaging.
Wang Y; Gao F
Korean J Radiol; 2023 Sep; 24(9):871-889. PubMed ID: 37634642
[TBL] [Abstract] [Full Text] [Related]
3. Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently.
Au TY; Arudkumar J; Assavarittirong C; Benjamin S
Clin Exp Med; 2023 Dec; 23(8):4163-4175. PubMed ID: 37500934
[TBL] [Abstract] [Full Text] [Related]
4. First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in cxcr4 and TRAF3 genes.
Zheng S; Lin L; Jin J; Liu F; Wei J; Feng Y; Zhang Y; Luo H; Qin J; Feng W
Int J Hematol; 2023 Sep; 118(3):394-399. PubMed ID: 36935465
[TBL] [Abstract] [Full Text] [Related]
5. Systemic Presentation of Somatic TET2 Mutated B-Cell lymphoma in a Child With Kabuki Syndrome and a Germline KMT2D Variant.
Kumar J; Alspach AE; Zucker JP; Gratzinger D
Am J Clin Pathol; 2022 Nov; 158(5):564-569. PubMed ID: 36048893
[TBL] [Abstract] [Full Text] [Related]
6. cxcr4 mediates leukemic cell migration and survival in the testicular microenvironment.
Skroblyn T; Joedicke JJ; Pfau M; Krüger K; Bourquin JP; Izraeli S; Eckert C; Höpken UE
J Pathol; 2022 Sep; 258(1):12-25. PubMed ID: 35522562
[TBL] [Abstract] [Full Text] [Related]
7. Cell surface expression of GRP78 and cxcr4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics.
Angeles-Floriano T; Rivera-Torruco G; García-Maldonado P; Juárez E; Gonzalez Y; Parra-Ortega I; Vilchis-Ordoñez A; Lopez-Martinez B; Arriaga-Pizano L; Orozco-Ruíz D; Torres-Nava JR; Licona-Limón P; López-Sosa F; Bremer A; Alvarez-Arellano L; Valle-Rios R
Sci Rep; 2022 Feb; 12(1):2322. PubMed ID: 35149705
[TBL] [Abstract] [Full Text] [Related]
8. Current approach to Waldenström Macroglobulinemia.
Ravi G; Kapoor P
Cancer Treat Res Commun; 2022; 31():100527. PubMed ID: 35149375
[TBL] [Abstract] [Full Text] [Related]
9. diagnosis and management of Waldenström macroglobulinaemia-A British Society for Haematology guideline.
Pratt G; El-Sharkawi D; Kothari J; D'Sa S; Auer R; McCarthy H; Krishna R; Miles O; Kyriakou C; Owen R
Br J Haematol; 2022 Apr; 197(2):171-187. PubMed ID: 35020191
[TBL] [Abstract] [Full Text] [Related]
10. Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
Zanwar S; Abeykoon JP; Ansell SM; Gertz MA; Colby C; Larson D; Paludo J; He R; Warsame R; Greipp PT; King RL; Thompson CA; Witzig TE; Lacy MQ; Gonsalves W; Nowakowski GS; Dingli D; Go RS; Habermann TM; Vincent Rajkumar S; Kyle RA; Kumar S; Kapoor P
Br J Haematol; 2021 Oct; 195(2):210-216. PubMed ID: 34340248
[TBL] [Abstract] [Full Text] [Related]
11. Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia.
Gayet M; Leymarie V; Derouault P; Guérin E; Vaidié J; Pascal V; Boulin M; Dmytruk N; Chauzeix J; Trimoreau F; Gachard N; Feuillard J; Rizzo D
Cytometry B Clin Cytom; 2022 Jan; 102(1):62-69. PubMed ID: 33634586
[TBL] [Abstract] [Full Text] [Related]
12. Improved Primary Staging of Marginal-Zone lymphoma by Addition of cxcr4-Directed PET/CT.
Duell J; Krummenast F; Schirbel A; Klassen P; Samnick S; Rauert-Wunderlich H; Rasche L; Buck AK; Wester HJ; Rosenwald A; Einsele H; Topp MS; Lapa C; Kircher M
J Nucl Med; 2021 Oct; 62(10):1415-1421. PubMed ID: 33579803
[TBL] [Abstract] [Full Text] [Related]
13. Management of Waldenström macroglobulinemia in 2020.
Castillo JJ; Treon SP
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):372-379. PubMed ID: 33275726
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS.
Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez de Villambrosia S; Gomez Mediavilla A; Urquieta Lam M; Insunza A; Tonda R; Beltran S; Gut M; Gonzalez A; Montes-Moreno S
J Clin Pathol; 2020 Sep; 73(9):571-577. PubMed ID: 31980558
[TBL] [Abstract] [Full Text] [Related]
15. Waldenstrom's macroglobulinemia in the era of immunotherapy.
Vaxman I; Gertz M
Leuk Lymphoma; 2020 Jun; 61(6):1292-1304. PubMed ID: 31960730
[TBL] [Abstract] [Full Text] [Related]
16. A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group.
Maqbool MG; Tam CS; Morison IM; Simpson D; Mollee P; Schneider H; Chan H; Juneja S; Harvey Y; Nath L; Hissaria P; Prince HM; Wordsworth H; Opat S; Talaulikar D
Pathology; 2020 Feb; 52(2):167-178. PubMed ID: 31902622
[TBL] [Abstract] [Full Text] [Related]
17. What is new in the treatment of Waldenstrom macroglobulinemia?
Castillo JJ; Treon SP
Leukemia; 2019 Nov; 33(11):2555-2562. PubMed ID: 31591468
[TBL] [Abstract] [Full Text] [Related]
18. Bone marrow recovery of hematopoietic stem cells and microenvironment after chemotherapy in childhood acute lymphoblastic leukemia: consecutive observations according to chemotherapy schedule.
Park SH; Lee MJ; Park CJ; Jang S; Seo EJ; Im HJ; Seo JJ
Pediatr Hematol Oncol; 2019 May; 36(4):222-235. PubMed ID: 31313940
[TBL] [Abstract] [Full Text] [Related]
19. Prospective non-invasive evaluation of cxcr4 expression for the diagnosis of MALT lymphoma using [
Haug AR; Leisser A; Wadsak W; Mitterhauser M; Pfaff S; Kropf S; Wester HJ; Hacker M; Hartenbach M; Kiesewetter-Wiederkehr B; Raderer M; Mayerhoefer ME
Theranostics; 2019; 9(12):3653-3658. PubMed ID: 31281504
[TBL] [Abstract] [Full Text] [Related]
20. [New molecular pathological strategies for malignant iris tumors].
Kakkassery V; Jünemann AM; Scheef BO; Grisanti S; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):324-331. PubMed ID: 30623224
[TBL] [Abstract] [Full Text] [Related]
[Next]
